Table 4.
Comparison of difference between before and after treatment in the two groups.
| Mass (Da) | Ave ± StdDev (A_H − A_Q) | Ave ± StdDev (B_H − B_Q) | P |
|---|---|---|---|
| 1329.42 | −4.18 ± 5.02 | 0.4 ± 6.86 | 0.005918 |
| 1519.06 | −7.1 ± 7.9 | −2.47 ± 9.08 | 0.046435 |
| 2660.01 | −82.12 ± 130.27 | 3.85 ± 184.48 | 0.047102 |
| 2881.04 | 4.86 ± 16.64 | −11.62 ± 23.4 | 0.003442 |
| 3207.37 | 6.56 ± 21.34 | −8.31 ± 19.09 | 0.008696 |
| 3277.49 | 14.13 ± 27.75 | −9.87 ± 33.72 | 0.005087 |
| 3972.15 | −8.69 ± 22.59 | 3.47 ± 15.5 | 0.02561 |
| 4279.95 | −2.49 ± 14.27 | 8.32 ± 19.41 | 0.020196 |
| 5066.25 | −0.43 ± 10.97 | 6.23 ± 13.8 | 0.049446 |
| 5807.76 | 18.84 ± 34.89 | −2.2 ± 36.2 | 0.031283 |
| 5822.51 | 9.44 ± 16.49 | −7.75 ± 32.03 | 0.013558 |
| 6088.68 | 8 ± 28.11 | −8.21 ± 25.58 | 0.029233 |
Note: paired sample t-test was used, 2-tailed, and P < 0.05 was considered significant; Ave: peak area/intensity average; StdDev: standard deviation of the peak area/intensity average; “A_H − A_Q”: subtraction between after and before treatment in group A; “B_H − B_Q”: subtraction between after and before treatment in group B; overstriking mass: unique to “Toxin.”